Home › Cancro colorettale › Utah › Salt Lake City
Studi clinici su Cancro colorettale a Salt Lake City, UT
22 studi su Cancro colorettale cercano partecipanti presso sedi a Salt Lake City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
In reclutamentoFase 1
- Huntsman Cancer Institute, Salt Lake City
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
In reclutamento
- University of Utah, Salt Lake City
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
In reclutamentoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
In reclutamentoFase 2/3
- Local Institution - 0426, Salt Lake City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
In reclutamentoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
In reclutamentoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Clinical Study Site, Salt Lake City
- Clinical Study Site, Salt Lake City
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- Huntsman Cancer Institute, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
In reclutamentoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Utah Cancer Specialists, Salt Lake City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Utah Cancer Specialists, Salt Lake City
- University of Utah Health Huntsman Cancer Hospital, Salt Lake City
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
In reclutamentoFase 1
- START Mountain Region, Salt Lake City
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
In reclutamentoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
In reclutamentoFase 1
- Huntsman Cancer Institute, Salt Lake City
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
In reclutamentoFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
In reclutamentoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
In reclutamentoFase 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
In reclutamentoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
ColoCare Study - Colorectal Cancer Cohort
In reclutamentoStudio osservazionale
- Huntsman Cancer Institute, Salt Lake City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
In reclutamentoStudio osservazionale
- Utah Cancer Specialists, Salt Lake City
Studi su Cancro colorettale in altre città
- Houston, TX102 studi
- New York City, NY78 studi
- Nashville, TN69 studi
- Boston, MA63 studi
- Los Angeles, CA59 studi
- Arlington, VA52 studi
- St. Louis, MO50 studi
- San Antonio, TX46 studi
- Philadelphia, PA44 studi
- Grand Rapids, MI40 studi
- Baldwin Park, CA37 studi
- Chicago, IL34 studi
Altri studi a Salt Lake City
- Cancro del polmone non a piccole cellule31 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno27 studi
- Cancro ai polmoni21 studi
- Melanoma21 studi
- Mieloma multiplo21 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Obesità18 studi
- Leucemia mieloide acuta17 studi
- Insufficienza cardiaca17 studi
- Cancro alla prostata15 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.